(Q37689272)

22 August 2017

Multiparametric magnetic resonance imaging findings in men with low-risk prostate cancer followed using active surveillance (English)

1 reference

22 August 2017

1 reference

5

Alan W Partin

1 reference

22 August 2017

7

H Ballentine Carter

1 reference

22 August 2017

3

Patricia Landis

1 reference

22 August 2017

6

Jonathan I Epstein

1 reference

22 August 2017

Jeffrey K Mullins

1

1 reference

22 August 2017

David Bonekamp

series ordinal

2

1 reference

22 August 2017

Hosne Begum

series ordinal

4

1 reference

22 August 2017

Katarzyna J Macura

series ordinal

8

1 reference

22 August 2017

6 March 2013

1 reference

22 August 2017

1 reference

22 August 2017

111

1 reference

22 August 2017

7

1 reference

22 August 2017

1037-1045

1 reference

National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer

22 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978179

Complications after prostate biopsy: data from SEER-Medicare

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978179

Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978179

Prostate cancer managed with active surveillance: role of anatomic MR imaging and MR spectroscopic imaging

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978179

Transition zone prostate cancers: features, detection, localization, and staging at endorectal MR imaging

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978179

Time trends in clinical risk stratification for prostate cancer: implications for outcomes (data from CaPSURE).

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978179

Prostate-specific antigen kinetics during follow-up are an unreliable trigger for intervention in a prostate cancer surveillance program

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978179

Changes in prostate cancer grade on serial biopsy in men undergoing active surveillance

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978179

Active surveillance program for prostate cancer: an update of the Johns Hopkins experience

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978179

Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978179

Localizing prostate cancer in the presence of postbiopsy changes on MR images: role of proton MR spectroscopic imaging

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978179

1 September 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11641.X

Prostate cancer vs. post-biopsy hemorrhage: Diagnosis with T2- and diffusion-weighted imaging

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1111%2FJ.1464-410X.2012.11641.X

Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer

21 January 2018

1 reference

12 December 2020

Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer

1 reference

12 December 2020

Combined T2-Weighted and Diffusion-Weighted MRI for Localization of Prostate Cancer

1 reference

12 December 2020

Dynamic contrast-enhanced MRI of anterior prostate cancer: morphometric assessment and correlation with radical prostatectomy findings

1 reference

12 December 2020

A Study of Diffusion-Weighted Magnetic Resonance Imaging in Men with Untreated Localised Prostate Cancer on Active Surveillance

1 reference

12 December 2020

Repeat prostate biopsies predict location of index cancer in an active surveillance cohort

1 reference

12 December 2020

Impact of Multiparametric Endorectal Coil Prostate Magnetic Resonance Imaging on Disease Reclassification Among Active Surveillance Candidates: A Prospective Cohort Study

1 reference

12 December 2020

Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance

1 reference

12 December 2020

Three-Tesla magnetic resonance-guided prostate biopsy in men with increased prostate-specific antigen and repeated, negative, random, systematic, transrectal ultrasound biopsies: detection of clinically significant prostate cancers

1 reference

12 December 2020

10.1111/J.1464-410X.2012.11641.X

Identifiers

DOI

1 reference

22 August 2017

1 reference

22 August 2017

PubMed publication ID

23464904

1 reference